The agreement would cover the company’s Caremark pharmacy benefit manager unit, which has denied wrongdoing.

CVS Health (CVS) has reached a deal with the U.S. Federal Trade Commission to settle allegations that its drug benefit manager (PBM), Caremark, artificially inflated the price of insulin through an ...

CVS Health's Caremark has become the second of the "Big Three" pharmacy benefit managers to reach a settlement with the Federal Trade Commission (FTC) in a lawsuit over insulin pricing. | CVS Health's ...

The FTC is now led by Chairman Andrew Ferguson, who backed Trump’s firing of FTC Democrats and disputed the previous ...

The task force will share resources and coordinate enforcement across the Federal Trade Commission’s disparate bureaus to ...

The Federal Trade Commission is launching a “Healthcare Task Force” to better focus its enforcement and advocacy on issues of competition and consumer protection within the industry, it announced F | ...

The Federal Trade Commission has sent warning letters to 97 auto dealer groups nationwide about deceptive pricing practices.

The MRC is urging the FTC to investigate Apple News, alleging the app published zero right-leaning stories in January while ...

By Jody Godoy PHILADELPHIA, March 17 (Reuters) - The U.S. Federal Trade Commission is on the lookout for anticompetitive ...

Republican Sen. Josh Hawley repeated his long-standing criticism of Fair Isaac Corp. in a letter noting the detrimental ...

A settlement between CVS' pharmacy benefit manager and antitrust regulators would leave UnitedHealth as the sole holdout in high-profile suit.